AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for ...

JPMorgan Chase today announced new responsibilities for several senior executives as it continues to build on its leadership positions across global financial services. Daniel Pinto, President and ...

“We are delighted to announce that Radiance Biopharma was chosen to present at Biotech Showcase 2025 in San Francisco,” said Robert Brooks, JD, Chief Executive Officer, of Radiance. “We are eager to ...

The current head of the Center for Medicare has advice for her successor: "Engaging everyone in the ecosystem" is the ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

The bank said profit rose 50% to $14 billion in the fourth quarter as noninterest expenses fell 7% from a year earlier.

CFO Aradhana Sarin outlined AstraZeneca’s plans at the 2025 JP Morgan Healthcare Conference in San Francisco on 15 January.

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

JPMorgan’s chief executive addressed growing speculation about who will replace him and said his successor might be a ...

While investors and analysts push for a deal, Biogen CEO Chris Viehbacher and Head of Development Priya Singhal refuse to ...

Pinto, the current president and COO, will retire at the end of 2026 after more than four decades at the bank, the company ...